Since their incorporation in October 2015, one of IBPL’s major research activity has been the fermentation of the bacterium – Haemophilus influenzae B (HIB) – for production of extracellular polysaccharide, which is a major constituent of vaccines such as meningococcal vaccine.
They have also been working on two separate projects: The first is a project offered by Dhampur Sugar Mills on membrane cell recycle continuous fermentation of dilute molasses to ethanol. This work is now nearing completion, and is expected to have an impact on minimizing the effluent of molasses fermentation, which is a priority for improving pollution control in the alcohol distillation industry.
In October 2016, they were also granted a project by SBIRI (BIRAC) for work on the Human Papilloma Virus vaccine using a recombinant yeast for production of Virus like particles (VLPs) that can be used in the manufacture of the quadrivalent vaccine against HPV. This is a dire need of the country as more than 270 million adolescent women/girls are at risk of cervical cancer against which the vaccine works.